IGF2BP3 and lung carcinoma: As shown in Figure 4D, lung cancer patients with high expression of IGF2BP3 had shorter survival rate compared to those with low expression of IGF2BP3.Thus, both in vitro and in vivo assays suggest that overexpression of IGF2BP3 promotes proliferation, metastasis and tumorigenicity of lung cancer cells.